INLEXZO™
(gemcitabine intravesical system)
Connect with us
Connect with us
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
INLEXZO™ (gemcitabine intravesical system)
Medical Information
INLEXZO - SunRISe-1 Study
Last Updated: 09/09/2025
Summary
A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:
- INLEXZO™ (gemcitabine intravesical system) - SunRISe-1 study
- Minimum requirement to access interactive content: Adobe Acrobat Reader
- The executive summary infographic of the iPDF content is provided below
- INLEXZO (gemcitabine intravesical system) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INLEXZO-pi.pdf.
- INLEXZO (gemcitabine intravesical system) [Instructions for Use]. Horsham, PA: Janssen Biotech, Inc; https://www.janssenlabels.com/package-insert/product-instructions-for-use/INLEXZO-ifu.pdf.